Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caloric Restriction | 2 | 2019 | 95 | 0.780 |
Why?
|
Exercise | 4 | 2019 | 663 | 0.670 |
Why?
|
Obesity | 4 | 2019 | 1158 | 0.630 |
Why?
|
Gene Expression | 2 | 2006 | 334 | 0.480 |
Why?
|
Geriatric Assessment | 10 | 2016 | 390 | 0.480 |
Why?
|
Disability Evaluation | 4 | 2019 | 238 | 0.470 |
Why?
|
Aged | 27 | 2019 | 10288 | 0.440 |
Why?
|
Aging | 8 | 2016 | 941 | 0.420 |
Why?
|
Cardiovascular Diseases | 3 | 2018 | 1122 | 0.410 |
Why?
|
Lung | 1 | 2013 | 255 | 0.390 |
Why?
|
Female | 35 | 2019 | 19859 | 0.370 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 161 | 0.360 |
Why?
|
Women's Health | 3 | 2016 | 235 | 0.340 |
Why?
|
Gene Expression Profiling | 2 | 2008 | 323 | 0.340 |
Why?
|
Motor Activity | 4 | 2016 | 325 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 912 | 0.310 |
Why?
|
Morphogenesis | 1 | 2008 | 9 | 0.310 |
Why?
|
Male | 31 | 2019 | 19091 | 0.310 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 69 | 0.300 |
Why?
|
Drosophila Proteins | 1 | 2008 | 45 | 0.300 |
Why?
|
Drosophila melanogaster | 1 | 2008 | 42 | 0.300 |
Why?
|
Oral Health | 4 | 2011 | 29 | 0.290 |
Why?
|
Aged, 80 and over | 16 | 2017 | 3988 | 0.280 |
Why?
|
Humans | 35 | 2019 | 31836 | 0.280 |
Why?
|
Biometry | 1 | 2006 | 13 | 0.270 |
Why?
|
Rural Population | 4 | 2012 | 273 | 0.270 |
Why?
|
Exercise Test | 3 | 2019 | 225 | 0.260 |
Why?
|
Computational Biology | 1 | 2005 | 91 | 0.250 |
Why?
|
Exercise Tolerance | 2 | 2019 | 124 | 0.230 |
Why?
|
Signal Transduction | 1 | 2008 | 687 | 0.230 |
Why?
|
Exercise Therapy | 3 | 2019 | 268 | 0.230 |
Why?
|
Tongue | 2 | 2012 | 13 | 0.200 |
Why?
|
Deglutition | 2 | 2011 | 29 | 0.190 |
Why?
|
Laryngoscopy | 2 | 2011 | 40 | 0.190 |
Why?
|
Respiratory Aspiration | 2 | 2011 | 21 | 0.190 |
Why?
|
Time Factors | 8 | 2011 | 2146 | 0.180 |
Why?
|
Prospective Studies | 7 | 2016 | 2277 | 0.180 |
Why?
|
Physical Fitness | 2 | 2012 | 131 | 0.180 |
Why?
|
Body Mass Index | 3 | 2019 | 916 | 0.170 |
Why?
|
Middle Aged | 18 | 2019 | 11824 | 0.170 |
Why?
|
Age Factors | 6 | 2012 | 1187 | 0.170 |
Why?
|
Fatigue | 1 | 2019 | 84 | 0.160 |
Why?
|
Oxygen Consumption | 1 | 2019 | 152 | 0.160 |
Why?
|
Risk Factors | 6 | 2018 | 3851 | 0.160 |
Why?
|
Hand Strength | 4 | 2012 | 100 | 0.160 |
Why?
|
Quality of Life | 6 | 2016 | 924 | 0.160 |
Why?
|
Diet | 2 | 2011 | 385 | 0.150 |
Why?
|
Reproducibility of Results | 3 | 2011 | 764 | 0.150 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 874 | 0.150 |
Why?
|
United States | 5 | 2018 | 3925 | 0.150 |
Why?
|
Cause of Death | 1 | 2018 | 238 | 0.150 |
Why?
|
Inflammation | 2 | 2012 | 540 | 0.140 |
Why?
|
Blood Glucose | 1 | 2019 | 491 | 0.140 |
Why?
|
Incidence | 2 | 2018 | 1192 | 0.140 |
Why?
|
Deglutition Disorders | 3 | 2011 | 50 | 0.140 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 493 | 0.140 |
Why?
|
Regression Analysis | 2 | 2008 | 293 | 0.140 |
Why?
|
Genes, Fungal | 2 | 2006 | 4 | 0.130 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 756 | 0.130 |
Why?
|
Diet Surveys | 3 | 2011 | 57 | 0.130 |
Why?
|
Computer Simulation | 2 | 2008 | 220 | 0.130 |
Why?
|
Cell Cycle | 2 | 2006 | 77 | 0.130 |
Why?
|
Independent Living | 1 | 2016 | 99 | 0.130 |
Why?
|
Cerebral Cortex | 2 | 2014 | 125 | 0.130 |
Why?
|
Patient Dropouts | 1 | 2015 | 28 | 0.130 |
Why?
|
Risk Assessment | 2 | 2018 | 1431 | 0.130 |
Why?
|
Models, Statistical | 2 | 2006 | 173 | 0.120 |
Why?
|
Activities of Daily Living | 1 | 2016 | 257 | 0.120 |
Why?
|
Cross-Sectional Studies | 7 | 2012 | 1527 | 0.120 |
Why?
|
Animals | 6 | 2012 | 7450 | 0.120 |
Why?
|
Survivors | 1 | 2016 | 159 | 0.120 |
Why?
|
Resistance Training | 1 | 2015 | 79 | 0.120 |
Why?
|
Mobility Limitation | 1 | 2016 | 219 | 0.120 |
Why?
|
Microarray Analysis | 2 | 2012 | 19 | 0.120 |
Why?
|
Behavior Therapy | 1 | 2014 | 102 | 0.120 |
Why?
|
Weight Loss | 2 | 2014 | 465 | 0.120 |
Why?
|
Movement | 1 | 2014 | 50 | 0.110 |
Why?
|
Algorithms | 2 | 2008 | 495 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2010 | 128 | 0.110 |
Why?
|
Patient Compliance | 1 | 2015 | 224 | 0.110 |
Why?
|
Motor Cortex | 2 | 2014 | 12 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2016 | 779 | 0.110 |
Why?
|
Food | 2 | 2011 | 43 | 0.110 |
Why?
|
Bacterial Translocation | 1 | 2012 | 8 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2012 | 10 | 0.110 |
Why?
|
Overweight | 1 | 2014 | 276 | 0.110 |
Why?
|
Dental Health Services | 1 | 2012 | 11 | 0.100 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 5 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2012 | 105 | 0.100 |
Why?
|
Life Style | 1 | 2014 | 407 | 0.100 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 102 | 0.100 |
Why?
|
Gastrointestinal Transit | 1 | 2011 | 4 | 0.100 |
Why?
|
Hypocalcemia | 1 | 2011 | 13 | 0.100 |
Why?
|
Carrier Proteins | 1 | 2012 | 137 | 0.100 |
Why?
|
Parathyroid Hormone | 1 | 2011 | 41 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2011 | 62 | 0.100 |
Why?
|
Infant Welfare | 1 | 2011 | 2 | 0.100 |
Why?
|
Cohort Studies | 5 | 2016 | 1824 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2011 | 18 | 0.100 |
Why?
|
Phonation | 1 | 2011 | 2 | 0.100 |
Why?
|
Maternal Welfare | 1 | 2011 | 8 | 0.100 |
Why?
|
Depression, Postpartum | 1 | 2011 | 9 | 0.100 |
Why?
|
Mother-Child Relations | 1 | 2011 | 15 | 0.100 |
Why?
|
Osteoarthritis | 1 | 2012 | 79 | 0.100 |
Why?
|
Muscle Strength | 1 | 2012 | 159 | 0.100 |
Why?
|
Xerostomia | 1 | 2011 | 30 | 0.090 |
Why?
|
Cognition | 2 | 2019 | 551 | 0.090 |
Why?
|
Cytokines | 1 | 2012 | 259 | 0.090 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2010 | 8 | 0.090 |
Why?
|
Adiposity | 1 | 2012 | 198 | 0.090 |
Why?
|
Biostatistics | 1 | 2010 | 7 | 0.090 |
Why?
|
Stomatognathic Diseases | 1 | 2010 | 5 | 0.090 |
Why?
|
Stroke | 2 | 2014 | 581 | 0.090 |
Why?
|
Infant, Premature, Diseases | 1 | 2010 | 24 | 0.090 |
Why?
|
Sex Factors | 4 | 2017 | 662 | 0.090 |
Why?
|
Social Support | 1 | 2011 | 180 | 0.090 |
Why?
|
Brain Diseases | 1 | 2010 | 38 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 151 | 0.090 |
Why?
|
Food Preferences | 1 | 2010 | 36 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2010 | 60 | 0.090 |
Why?
|
Bicycling | 1 | 2009 | 14 | 0.090 |
Why?
|
Cardiac Output | 1 | 2009 | 36 | 0.090 |
Why?
|
Mouth, Edentulous | 1 | 2009 | 4 | 0.090 |
Why?
|
Nutrition Disorders | 1 | 2009 | 12 | 0.090 |
Why?
|
Dental Care for Aged | 1 | 2009 | 6 | 0.090 |
Why?
|
Health Surveys | 3 | 2016 | 196 | 0.090 |
Why?
|
Oral Hygiene | 1 | 2009 | 16 | 0.090 |
Why?
|
Probability | 2 | 2009 | 158 | 0.080 |
Why?
|
Heart Failure, Diastolic | 1 | 2009 | 15 | 0.080 |
Why?
|
Geriatrics | 1 | 2010 | 85 | 0.080 |
Why?
|
Nutritional Status | 1 | 2009 | 75 | 0.080 |
Why?
|
Neoplasms | 1 | 2016 | 692 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2010 | 161 | 0.080 |
Why?
|
Sepsis | 1 | 2010 | 158 | 0.080 |
Why?
|
Lower Extremity | 1 | 2009 | 100 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 135 | 0.080 |
Why?
|
Capillaries | 1 | 2008 | 24 | 0.080 |
Why?
|
Biomedical Research | 1 | 2010 | 155 | 0.080 |
Why?
|
Quadriceps Muscle | 1 | 2008 | 34 | 0.080 |
Why?
|
Nutrition Surveys | 1 | 2009 | 147 | 0.080 |
Why?
|
Cell Differentiation | 1 | 2010 | 468 | 0.080 |
Why?
|
Models, Animal | 1 | 2008 | 164 | 0.080 |
Why?
|
Health Status | 3 | 2016 | 397 | 0.080 |
Why?
|
Health Behavior | 1 | 2009 | 231 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 109 | 0.070 |
Why?
|
Comorbidity | 1 | 2009 | 566 | 0.070 |
Why?
|
Macaca fascicularis | 1 | 2008 | 397 | 0.070 |
Why?
|
Dementia | 1 | 2009 | 251 | 0.070 |
Why?
|
Genes, Insect | 1 | 2006 | 4 | 0.070 |
Why?
|
Least-Squares Analysis | 1 | 2006 | 33 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 2006 | 20 | 0.070 |
Why?
|
North Carolina | 4 | 2012 | 1514 | 0.070 |
Why?
|
Ethanol | 1 | 2008 | 186 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 1424 | 0.070 |
Why?
|
Dictyostelium | 1 | 2005 | 1 | 0.070 |
Why?
|
Stochastic Processes | 1 | 2005 | 4 | 0.070 |
Why?
|
Fungal Proteins | 1 | 2005 | 6 | 0.070 |
Why?
|
Normal Distribution | 1 | 2005 | 12 | 0.070 |
Why?
|
Models, Genetic | 1 | 2006 | 94 | 0.070 |
Why?
|
Drosophila | 1 | 2006 | 35 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2008 | 247 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2005 | 68 | 0.070 |
Why?
|
Models, Biological | 1 | 2008 | 391 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2014 | 2271 | 0.060 |
Why?
|
Linear Models | 3 | 2012 | 449 | 0.060 |
Why?
|
Software | 1 | 2005 | 127 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2012 | 686 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2009 | 515 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2009 | 540 | 0.060 |
Why?
|
Heart Failure | 1 | 2009 | 620 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2017 | 239 | 0.050 |
Why?
|
Odds Ratio | 2 | 2016 | 470 | 0.050 |
Why?
|
Hypertension | 1 | 2009 | 956 | 0.050 |
Why?
|
Laryngoscopes | 2 | 2011 | 12 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 3294 | 0.050 |
Why?
|
Reference Values | 2 | 2011 | 247 | 0.050 |
Why?
|
Brain Mapping | 2 | 2014 | 178 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 298 | 0.050 |
Why?
|
European Continental Ancestry Group | 2 | 2017 | 1169 | 0.040 |
Why?
|
Body Composition | 2 | 2014 | 388 | 0.040 |
Why?
|
Logistic Models | 2 | 2012 | 777 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 589 | 0.040 |
Why?
|
Executive Function | 1 | 2019 | 57 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 766 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2011 | 665 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 420 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 370 | 0.040 |
Why?
|
Lysine | 1 | 2017 | 23 | 0.040 |
Why?
|
African Continental Ancestry Group | 1 | 2017 | 363 | 0.030 |
Why?
|
Continental Population Groups | 1 | 2017 | 236 | 0.030 |
Why?
|
Mice | 2 | 2012 | 2476 | 0.030 |
Why?
|
Demography | 1 | 2015 | 110 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2015 | 73 | 0.030 |
Why?
|
Heart Rate | 1 | 2017 | 332 | 0.030 |
Why?
|
Length of Stay | 1 | 2016 | 315 | 0.030 |
Why?
|
Recruitment, Neurophysiological | 1 | 2014 | 2 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2014 | 6 | 0.030 |
Why?
|
Motor Skills | 1 | 2014 | 13 | 0.030 |
Why?
|
Functional Laterality | 1 | 2014 | 56 | 0.030 |
Why?
|
Electromyography | 1 | 2014 | 59 | 0.030 |
Why?
|
Health Education | 1 | 2014 | 157 | 0.030 |
Why?
|
Diet, Reducing | 1 | 2014 | 102 | 0.030 |
Why?
|
Upper Extremity | 1 | 2014 | 57 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2014 | 99 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2014 | 148 | 0.030 |
Why?
|
Chemokine CCL21 | 1 | 2012 | 2 | 0.030 |
Why?
|
Stifle | 1 | 2012 | 4 | 0.030 |
Why?
|
Interleukins | 1 | 2012 | 19 | 0.030 |
Why?
|
Esophageal Motility Disorders | 1 | 2011 | 6 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 45 | 0.030 |
Why?
|
Viscosity | 1 | 2011 | 22 | 0.030 |
Why?
|
Hindlimb | 1 | 2012 | 54 | 0.030 |
Why?
|
Tibia | 1 | 2012 | 56 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2011 | 6 | 0.020 |
Why?
|
Gait | 1 | 2012 | 140 | 0.020 |
Why?
|
Cartilage, Articular | 1 | 2012 | 76 | 0.020 |
Why?
|
Indians, North American | 1 | 2011 | 109 | 0.020 |
Why?
|
ROC Curve | 1 | 2011 | 167 | 0.020 |
Why?
|
Beverages | 1 | 2011 | 19 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2011 | 37 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 4 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 12 | 0.020 |
Why?
|
Psychometrics | 1 | 2011 | 136 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2011 | 122 | 0.020 |
Why?
|
Educational Status | 1 | 2011 | 178 | 0.020 |
Why?
|
Rural Health | 1 | 2010 | 44 | 0.020 |
Why?
|
Electroencephalography | 1 | 2010 | 72 | 0.020 |
Why?
|
Poverty | 1 | 2011 | 111 | 0.020 |
Why?
|
Equipment Design | 1 | 2010 | 172 | 0.020 |
Why?
|
Infant, Premature | 1 | 2010 | 68 | 0.020 |
Why?
|
Gestational Age | 1 | 2010 | 120 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 262 | 0.020 |
Why?
|
Bone Marrow | 1 | 2010 | 70 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2012 | 245 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2011 | 461 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2009 | 86 | 0.020 |
Why?
|
Femoral Artery | 1 | 2009 | 48 | 0.020 |
Why?
|
Iliac Artery | 1 | 2009 | 49 | 0.020 |
Why?
|
Calcium | 1 | 2011 | 304 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 48 | 0.020 |
Why?
|
Waiting Lists | 1 | 2009 | 34 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2009 | 113 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 85 | 0.020 |
Why?
|
Restraint, Physical | 1 | 2008 | 10 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 297 | 0.020 |
Why?
|
Research Design | 1 | 2010 | 310 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2010 | 833 | 0.020 |
Why?
|
Prevalence | 1 | 2011 | 979 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 240 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 211 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2009 | 191 | 0.020 |
Why?
|
Walking | 1 | 2009 | 208 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2009 | 251 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 994 | 0.020 |
Why?
|
Infant | 1 | 2011 | 1055 | 0.020 |
Why?
|
Recovery of Function | 1 | 2008 | 199 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2009 | 895 | 0.020 |
Why?
|
Chronic Disease | 1 | 2009 | 400 | 0.020 |
Why?
|
Self Administration | 1 | 2008 | 297 | 0.020 |
Why?
|
Smoking | 1 | 2011 | 499 | 0.020 |
Why?
|
Stroke Volume | 1 | 2009 | 341 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 899 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 513 | 0.020 |
Why?
|
African Americans | 1 | 2011 | 1428 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 2603 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 1323 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 3488 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 3511 | 0.010 |
Why?
|
Adult | 1 | 2011 | 9327 | 0.010 |
Why?
|